Atrial Fibrillation Research

Published Online: Tuesday, January 14, 2014
Follow Pharmacy_Times:
Chris Cannon, MD, FACC, discusses 3 research papers on atrial fibrillation in this video produced by the American College of Cardiology.

Related Articles
In a Phase 3 study, odanacatib significantly reduced the risk of osteoporotic fractures, but it also might have contributed to major cardiovascular events.
Approximately 6.5 million Americans are prescribed digoxin, a cardiac glycoside with a long, fascinating history.
Statin guidelines released jointly by the American Heart Association and the American College of Cardiology more accurately identify patients with heavy arterial plaque buildup for therapy.
Several new anticoagulants have entered the US market in recent years, but research to find reversal agents for these drugs is ongoing.
Latest Issues
$auto_registration$